SinoMab BioScience Margen bruto
¿Qué es el Margen bruto de SinoMab BioScience?
El Margen bruto de SinoMab BioScience Limited es 78.59%
¿Cuál es la definición de Margen bruto?
El margen bruto es la diferencia entre el ingreso y el costo de los bienes vendidos, dividido por el ingreso y expresado como un porcentaje.
Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.
Margen bruto de compañías en Sector Health Care en HKSE en comparadas con SinoMab BioScience
¿Qué hace SinoMab BioScience?
SinoMab BioScience Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of therapeutics for the treatment of immunological diseases, primarily monoclonal antibody (mAb)-based biologics. Its flagship product is SM03, a first-in-target anti-CD22 mAb, which is in Phase III clinical trial for the treatment of rheumatoid arthritis (RA), as well as in various clinical stages for other immunological diseases, such as systemic lupus erythematosus (SLE), Sjogren's syndrome (SS), and non-Hodgkin's lymphoma (NHL). The company also focuses on developing SN1011, a Bruton's tyrosine kinase inhibitor, which is Phase I clinical trial for the treatment of RA, SLE, pemphigus, multiple sclerosis, and other immunological diseases. Its products under preclinical stage comprise SM17 for the treatment of asthma and idiopathic pulmonary fibrosis; SM09 that is used for the treatment of NHL and RA; SM06 for use in treating RA, SLE, and SS; and TNF2 for the treatment of RA. The company operates in Mainland China, the Cayman Islands, and Hong Kong. SinoMab BioScience Limited was incorporated in 2001 and is headquartered in Pak Shek Kok, Hong Kong.
Empresas con margen bruto similar a SinoMab BioScience
- Rua Life Sciences Plc tiene Margen bruto de 78.54%
- Acrow Formwork and Construction Services tiene Margen bruto de 78.56%
- Uniti tiene Margen bruto de 78.57%
- LifeTech Scientific tiene Margen bruto de 78.57%
- Servicenow Dl ,001 tiene Margen bruto de 78.59%
- ServiceNow Inc tiene Margen bruto de 78.59%
- SinoMab BioScience tiene Margen bruto de 78.59%
- Tera Software tiene Margen bruto de 78.59%
- i-nexus Global plc tiene Margen bruto de 78.59%
- F-Secure Oyj tiene Margen bruto de 78.60%
- Magellan tiene Margen bruto de 78.61%
- Prozone Intu Properties tiene Margen bruto de 78.63%
- Pandora AS tiene Margen bruto de 78.63%